Evolving Paradigms for Insulin Therapy of Type 2 Diabetes
A 3-Part Series
Diabetes is a chronic, highly prevalent disease. Despite the availability of many new treatment options, including new insulin formulations that have the potential to simplify treatment regimens, improve treatment adherence, and provide clinical benefit, patients often have poor glycemic control. This interactive multidisciplinary series examines challenges encountered in the management of T2DM and the many therapeutic options available to clinicians.Target audience:
Endocrinologists, primary care physicians, and other members of the care team involved in the management of patients with T2DM, including endocrinology and primary care nurse practitioners (NPs) and physician assistants (PAs), nurses, and dietitians.
Louis H. Philipson MD, PhD
Neda Laiteerapong, MD, MS, FACP
Amy Hess-Fischl, MS, RDN, LDN, BC-ADM, CDE